Natural Products as Leads for Tuberculosis Drug Development

被引：1

作者：

Salomon, Christine E. ^{[1
]}

Schmidt, Lori E. ^{[1
]}

机构：

[1] Univ Minnesota, Ctr Drug Design, Minneapolis, MN 55455 USA

来源：

CURRENT TOPICS IN MEDICINAL CHEMISTRY | 2012年 / 12卷 / 07期

关键词：

Natural products; tuberculosis; drug development; mycobacterium tuberculosis; drug resistant tuberculosis; structure activity relationship; ENDIANDRIC ACID CASCADE; RESISTANT MYCOBACTERIUM-TUBERCULOSIS; STEREOCONTROLLED TOTAL-SYNTHESIS; PSEUDOMONAS SP F92S91; TUMOR-CELL LINES; ANTIMYCOBACTERIAL ACTIVITY; ANTITUBERCULAR CONSTITUENTS; GROWTH-INHIBITORS; ORGANIC-SYNTHESIS; SECONDARY METABOLITES;

D O I：

暂无

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

New therapeutics are urgently needed to combat the immense disease burden of tuberculosis and related mycobacterial diseases worldwide. Natural products continue to provide leads for the development of novel drugs to treat the rapidly growing numbers of patients with multi- and extensively-drug resistant tuberculosis. This review presents natural products and synthesized analogues with anti-mycobacterial activity published between 2006 through 2009. Structure activity relationships, synthetic analogues and newly reported activities of known compounds reported during this period are also included.

引用

页码：735 / 765

页数：31

共 50 条

[41] Updates on Managing Type 2 Diabetes Mellitus with Natural Products: Towards Antidiabetic Drug Development [J].

Alam, Fahmida ;

Islam, Md. Asiful ;

Kamal, Mohammad Amjad ;

Gan, Siew Hua .

CURRENT MEDICINAL CHEMISTRY, 2018, 25 (39) :5395-5431

[42] Selective Killing of Dormant Mycobacterium tuberculosis by Marine Natural Products [J].

Felix, Carolina Rodrigues ;

Gupta, Rashmi ;

Geden, Sandra ;

Roberts, Jill ;

Winder, Priscilla ;

Pomponi, Shirley A. ;

Diaz, Maria Cristina ;

Reed, John K. ;

Wright, Amy E. ;

Rohde, Kyle H. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (08)

[43] Harnessing nutrients and natural products for sustainable drug development against aging [J].

Ding, Fuan ;

Yu, Ying ;

Zhang, Yan ;

Wei, Shibo ;

Han, Jung Ho ;

Li, Zhuo ;

Jiang, Hong-Bo ;

Ryu, Dongryeol ;

Park, Wonyoung ;

Ha, Ki-Tae ;

Geng, Li .

FRONTIERS IN PHARMACOLOGY, 2025, 16

[44] New drug discovery and development from natural products: Advances and strategies [J].

Wang, Yixin ;

Wang, Fan ;

Liu, Wenxiu ;

Geng, Yifei ;

Shi, Yahong ;

Tian, Yu ;

Zhang, Bin ;

Luo, Yun ;

Sun, Xiaobo .

PHARMACOLOGY & THERAPEUTICS, 2024, 264

[45] Targeting the mycobacterial envelope for tuberculosis drug development [J].

Favrot, Lorenza ;

Ronning, Donald R. .

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (09) :1023-1036

[46] Tuberculosis susceptibility - Implications for drug development and therapy [J].

Snell, NJC .

EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (09) :1455-1460

[47] New perspectives on natural products in TB drug research [J].

Pauli, GF ;

Case, RJ ;

Inui, T ;

Wang, YH ;

Cho, SY ;

Fischer, NH ;

Franzblau, SG .

LIFE SCIENCES, 2005, 78 (05) :485-494

[48] The structural modification of natural products for novel drug discovery [J].

Yao, Hong ;

Liu, Junkai ;

Xu, Shengtao ;

Zhu, Zheying ;

Xu, Jinyi .

EXPERT OPINION ON DRUG DISCOVERY, 2017, 12 (02) :121-140

[49] The Potential of Natural Diterpenes Against Tuberculosis: An Updated Review [J].

Ndjoubi, Kadidiatou O. ;

Sharma, Rajan ;

Hussein, Ahmed A. .

CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (24) :2909-2932

[50] Drug Design and Identification of Potent Leads Against Mycobacterium tuberculosis Thymidine Monophosphate Kinase [J].

Van Calenbergh, S. ;

Pochet, S. ;

Munier-Lehmann, H. .

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2012, 12 (07) :694-705

← 1 2 3 4 5 →